In Reply to Khalifa and Sargos

We thank the authors for their comments1 on our publication titled “Phase I trial of atezolizumab plus trimodal therapy (TMT) in patients with localized muscle-invasive bladder cancer (MIBC)” published in this journal.2

Source: International Journal of Radiation Oncology * Biology * Physics - June 3, 2021 Category: Radiology Authors: Gautier Marcq, Luis Souhami, Wassim Kassouf Tags: Comments Source Type: research